The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction

NCT ID: NCT05448898

Last Updated: 2022-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

278 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-15

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studies have demonstrated that patients with olfactory dysfunction could improve the olfactory function after olfactory training. But the efficacy of Traditional Chinese Medicine is unknown.The purpose of this study is to evaluate its efficacy in olfactory dysfunction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A recent meta-analysis found significant positive effects of olfactory training on the individual subcomponents of odor threshold, discrimination, identification, and the composite TDI score. In addition to the evidenced improvement in olfactory function after olfactory training, this form of treatment carries very little risk of adverse effects, is cheap, and can be administered by the patient. For these collective reasons, olfactory training is an attractive treatment modality. Chinese experts consensus on diagnosis and treatment of olfactory dysfunction in 2017 shown that some evidences proved that Traditional Chinese Medicine treatment would benefit olfactory dysfunction but the evidences is not adequate. Until now, the efficacy of Traditional Chinese Medicine is controversial. This study investigate the efficacy and the safety of Traditional Chinese Medicine and olfactory training as a treatment for patients with olfactory dysfunction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Olfactory Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Traditional Chinese Medicine with olfactory training

Traditional Chinese Medicine therapy:

Oral Traditional Chinese Medicine CU Xiu Tang once a day for at least 3 months

Olfactory training:

repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months

Group Type EXPERIMENTAL

Traditional Chinese Medicine CU Xiu Tang

Intervention Type DRUG

Oral Traditional Chinese Medicine CU Xiu Tang once a day and repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months

Olfactory Training

Intervention Type OTHER

repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months

Olfactory training

repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months

Group Type EXPERIMENTAL

Olfactory Training

Intervention Type OTHER

repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Traditional Chinese Medicine CU Xiu Tang

Oral Traditional Chinese Medicine CU Xiu Tang once a day and repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months

Intervention Type DRUG

Olfactory Training

repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Olfactory Training

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Clinical diagnosis of Olfactory dysfunction;
2. 18 ≤ age ≤ 55 years old;
3. No active infection, such as uncontrolled pneumonia;
4. Women with reproductive potential and sexually active men agree to use acceptable and effective contraceptive methods.

Exclusion Criteria

1. Refuse to sign informed consent;
2. With other diseases that affect the result, such as severe hepatic and renal dysfunction and the investigators believes will interfere with the treatment;
3. Pregnant or lactating women;
4. Without personal freedom and independent civil capacity;
5. Enrolled in other intervention clinical trials;
6. Autoimmune diseases;
7. Other situations that the investigators think are not suitable for the trial.
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eye & ENT Hospital of Fudan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hongmeng Yu, Dr

Role: PRINCIPAL_INVESTIGATOR

Eye & ENT Hospital, Fudan University

YanQing Li, Dr

Role: PRINCIPAL_INVESTIGATOR

Eye & ENT Hospital, Fudan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eye & ENT Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hongmeng Yu, Dr

Role: CONTACT

13501730576

Qi Dai, Dr

Role: CONTACT

18717835116

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

hongmeng Yu, Dr

Role: primary

13501730576

Qi Dai, Dr

Role: backup

18717835116

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ODCT2002-6

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.